메뉴 건너뛰기
American Journal of the Medical Sciences
Volumn 318, Issue 3, 1999, Pages 203-205
Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: Response to octreotide
Author keywords

Carcinoid; Cytokines; Hypercalcemia; Octreotide
Indexed keywords

INTERLEUKIN 6; OCTREOTIDE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN;
EID: 0033511643     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)40616-0     Document Type: Article
Times cited : (18)
References (8)
  • 1
    • 0024532245 scopus 로고
    • Multiple forms of parathyroid hormone-like protein in a human tumour
    • Docherty HM, Heath DA. Multiple forms of parathyroid hormone-like protein in a human tumour. J Mol Endocrinol 1989;2:11-20.
    • (1989) J Mol Endocrinol , vol.2 , pp. 11-20
    • Docherty, H.M.1    Heath, D.A.2
  • 2
    • 0031002224 scopus 로고    scopus 로고
    • Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumor
    • Oxf
    • Mantzoros CS, Suva LJ, Moses AC, et al. Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumor. Clin Endocrinol (Oxf) 1997; 46:373-5.
    • (1997) Clin Endocrinol , vol.46 , pp. 373-375
    • Mantzoros, C.S.1    Suva, L.J.2    Moses, A.C.3
  • 3
    • 0028925088 scopus 로고
    • Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis
    • Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332:305-11.
    • (1995) N Engl J Med , vol.332 , pp. 305-311
    • Manolagas, S.C.1    Jilka, R.L.2
  • 4
    • 0029051328 scopus 로고
    • Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
    • De La Mata J, Uy HL, Guise TA, et al. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest 1995;95:2846-2852.
    • (1995) J Clin Invest , vol.95 , pp. 2846-2852
    • De La Mata, J.1    Uy, H.L.2    Guise, T.A.3
  • 5
    • 0027336773 scopus 로고
    • Molecular mechanisms of somatostatin's inhibition of hormone release: Participation of voltage-gated calcium channels and G-proteins
    • Scherubl H, Hescheler J, Riecken EO. Molecular mechanisms of somatostatin's inhibition of hormone release: participation of voltage-gated calcium channels and G-proteins. Hormone Metab Res 1993;27(Suppl):1-4.
    • (1993) Hormone Metab Res , vol.27 , Issue.SUPPL. , pp. 1-4
    • Scherubl, H.1    Hescheler, J.2    Riecken, E.O.3
  • 6
    • 0025873753 scopus 로고
    • Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors
    • Wynick D, Bloom SR. Clinical review 23: the use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors. J Clin Endocrinol Metab 1991; 73:1-3.
    • (1991) J Clin Endocrinol Metab , vol.73 , pp. 1-3
    • Wynick, D.1    Bloom, S.R.2
  • 7
    • 0023905952 scopus 로고
    • Hypercalcaemia of malignancy
    • Heath DA, Docherty HM. Hypercalcaemia of malignancy. Lancet 1988;1:308-9.
    • (1988) Lancet , vol.1 , pp. 308-309
    • Heath, D.A.1    Docherty, H.M.2
  • 8
    • 0008036749 scopus 로고
    • Somatostatin
    • Groot LJ, editor. Philadelphia: Saunders
    • Wass JAH. Somatostatin. In: Groot LJ, editor. Endocrinology. 3rd ed. Philadelphia: Saunders; 1995. p. 266-79.
    • (1995) Endocrinology. 3rd Ed. , pp. 266-279
    • Wass, J.A.H.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.